इसराइल - अंग्रेज़ी - Ministry of Health

unipharm ltd, israel - alendronate as sodium - tablets - alendronate as sodium 70 mg - alendronic acid - alendronic acid - maxibone is indicated for the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip and spine (vertebral compression fractures).treatment to increase bone mass in men with osteoporosis.

इसराइल - अंग्रेज़ी - Ministry of Health

unipharm ltd, israel - tadalafil - film coated tablets - tadalafil 10 mg - tadalafil - for the treatment of erectile dysfunction in adult men.

इसराइल - अंग्रेज़ी - Ministry of Health

unipharm ltd, israel - tadalafil - film coated tablets - tadalafil 20 mg - tadalafil - for the treatment of erectile dysfunction in adult men.

इसराइल - अंग्रेज़ी - Ministry of Health

unipharm ltd, israel - tadalafil - film coated tablets - tadalafil 5 mg - tadalafil - for the treatment of erectile dysfunction in adult men.treatment of the signs and symptoms of benign prostatic hyperplasia (bph)treatment of ed and the signs and symptoms of bph (ed/bph)

इसराइल - अंग्रेज़ी - Ministry of Health

unipharm ltd, israel - clopidogrel as hydrogen sulfate - tablets - clopidogrel as hydrogen sulfate 75 mg - clopidogrel - prevention of atherotrobmotic eventsclopidogrel is indicated in :• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapyprevention of atherotrobmotic and thromboembolic events in atrial fibrillation: in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke.

इसराइल - अंग्रेज़ी - Ministry of Health

teva pharmaceutical industries ltd, israel - mirtazapine - tablets - mirtazapine 30 mg - mirtazapine - mirtazapine - episode of major depression.

इसराइल - अंग्रेज़ी - Ministry of Health

teva pharmaceutical industries ltd, israel - mirtazapine - tablets - mirtazapine 30 mg - mirtazapine - mirtazapine - episode of major depression.

इसराइल - अंग्रेज़ी - Ministry of Health

teva pharmaceutical industries ltd, israel - mirtazapine - tablets - mirtazapine 45 mg - mirtazapine - mirtazapine - episode of major depression.

इसराइल - अंग्रेज़ी - Ministry of Health

teva pharmaceutical industries ltd, israel - mirtazapine - tablets - mirtazapine 45 mg - mirtazapine - mirtazapine - episode of major depression.

इसराइल - अंग्रेज़ी - Ministry of Health

teva pharmaceutical industries ltd, israel - furosemide - tablets - furosemide 40 mg - furosemide - furosemide - edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. adjunctive therapy in acute pulmonary edema. treatment of hypertension.